337 related articles for article (PubMed ID: 7916335)
21. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
Bradwejn J
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
[TBL] [Abstract][Full Text] [Related]
22. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
Reynolds DS
Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
[TBL] [Abstract][Full Text] [Related]
23. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
24. Neural and molecular mechanisms in anxiety.
Wolkowitz OM; Paul SM
Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577
[TBL] [Abstract][Full Text] [Related]
25. Anxiolytics: past, present, and future agents.
Nemeroff CB
J Clin Psychiatry; 2003; 64 Suppl 3():3-6. PubMed ID: 12662127
[TBL] [Abstract][Full Text] [Related]
26. Anxiolytic profiles.
Gershon S; Eison AS
J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
[TBL] [Abstract][Full Text] [Related]
27. Azapirones: an alternative to benzodiazepines for anxiety.
Cadieux RJ
Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
[TBL] [Abstract][Full Text] [Related]
28. CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies.
Harro J
Amino Acids; 2006 Oct; 31(3):215-30. PubMed ID: 16738800
[TBL] [Abstract][Full Text] [Related]
29. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
30. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
Briones-Aranda A; López-Rubalcava C; Picazo O
Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
[TBL] [Abstract][Full Text] [Related]
31. The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats.
Lodge DJ; Lawrence AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):451-8. PubMed ID: 12691780
[TBL] [Abstract][Full Text] [Related]
32. Research in anxiety disorders: from the bench to the bedside.
Garner M; Möhler H; Stein DJ; Mueggler T; Baldwin DS
Eur Neuropsychopharmacol; 2009 Jun; 19(6):381-90. PubMed ID: 19327970
[TBL] [Abstract][Full Text] [Related]
33. Use of drugs in the treatment of anxiety.
Vajda FJ; Burrows GD
Aust Fam Physician; 1983 Oct; 12(10):714-7. PubMed ID: 6141784
[TBL] [Abstract][Full Text] [Related]
34. Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA/benzodiazepine receptor complex.
López-Rubalcava C; Piña-Medina B; Estrada-Reyes R; Heinze G; Martínez-Vázquez M
Life Sci; 2006 Jan; 78(7):730-7. PubMed ID: 16122763
[TBL] [Abstract][Full Text] [Related]
35. Neurobiologic basis of anxiety and its treatment.
Salzman C; Miyawaki EK; le Bars P; Kerrihard TN
Harv Rev Psychiatry; 1993; 1(4):197-206. PubMed ID: 9384849
[TBL] [Abstract][Full Text] [Related]
36. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacology of anxiolytics and their therapeutic use].
Tada K
Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
[No Abstract] [Full Text] [Related]
38. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
39. [A new generation of tranquilizing agents].
Escande M; Frexinos M; Fabre S
Rev Prat; 1994 Nov; 44(17):2316-9. PubMed ID: 7984939
[TBL] [Abstract][Full Text] [Related]
40. Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.
Haefely W; Facklam M; Schoch P; Martin JR; Bonetti EP; Moreau JL; Jenck F; Richards JG
Adv Biochem Psychopharmacol; 1992; 47():379-94. PubMed ID: 1324584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
